
Formulary Search
You are here : Home > Formulary Search
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
A to Z of Drugs : N
Records returned : 61 (on 29 May 2025 at 00:28:15).
Show Icon and Status Keys Hide Icon and Status Keys
Icon Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
Cancer Drugs Fund
ICB
Treatment commissioned by the ICB
Link to the NICE website

Low carbon device
Status Key
Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
See narrative
See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Red
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Nasal spray
Restrictions / Comments:
Formulary Status :
Links :
SPC
NFD1
Indication :
Status :
Amber
Formulations :
- Nasal spray
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Amber
Formulations :
- Nasal spray
Restrictions / Comments:
Important
EXISTING patients only. Do not initiate in new patients.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Important
Opioid-induced constipation.
Only after other laxatives have been unsuccessful.
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Tablets
Restrictions / Comments:
Important
Opioid-induced constipation.
Only after other laxatives have been unsuccessful.
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
Please check TOXBASE for further information. https://www.toxbase.org/ . Intramuscular and intranasal preparations are available for use in non-medical settings
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Nasal spray
Restrictions / Comments:
Important
May be given intranasally in non-medical settings.
See Healthy Surrey website for details on accessing naloxone nasal spray in the community https://www.healthysurrey.org.uk/drugs-and-alcohol/naloxone
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
https://www.toxbase.org/ . May be given by intramuscular injection in non-medical settings.
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Effervescent tablets
- Oral suspension
Restrictions / Comments:
Important
Effervescent tablets and oral suspension are much more expensive and should be reserved for patients in whom ibuprofen suspension is not suitable. Reserve oral suspension for patients with sodium restriction or for children.
Formulary Status :
Links :
SPC
R
Indication :
Status :
Non Formulary
Formulations :
- Gastro-resistant tablets
Restrictions / Comments:
Important
More expensive that standard tablets and offer no additional gastro-protection.
Formulary Status :
Links :
SPC
NFD1
Indication :
Status :
Non Formulary
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
SPC
NFD1
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Prescribe generically
Links :
Indication :
Status :
Red
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
Prescribing in primary care on specialist recommendation.
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Tablets
Restrictions / Comments:
Important
Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Tablets
Restrictions / Comments:
Important
Reserve for when alternatives are contraindicated or ineffective.
At RSFT - initiation by pain team only.
Links :
Indication :
Status :
Red
Formulations :
- Solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Eye drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Oral solution
Restrictions / Comments:
Important
Restricted use - prevention of vertical transmission in babies born to HIV-positive mothers. Use as recommended in BHIVA guidelines
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Important
Specialist only
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
SPC
NFD1
Indication :
Status :
Green
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Prescribe by BRAND.
Tensipine MR (Twice daily) and Adipine XL (once daily) are the preferred tablet brands.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
Prescribe by BRAND.
Coracten SR (Twice daily) and Coracten XL (once daily) are the preferred capsule brands.
Links :
Indication :
Status :
Red
Formulations :
- Capsules
Restrictions / Comments:
Important
Use by palliative care teams.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Prescribe by BRAND
Tensipine MR (Twice daily) and Adipine XL (once daily) are the preferred tablet brands.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
Prescribe by BRAND
Coracten SR (Twice daily) and Coracten XL (once daily) are the preferred capsule brands.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Capsules
Restrictions / Comments:
Important
Prescribe by BRAND
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Capsules
Restrictions / Comments:
Important
Use by palliative care teams.
Formulary Status :
Links :
SPC
Un
Indication :
Status :
Red
Formulations :
- Intravenous infusion
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Capsules
Restrictions / Comments:
Important
NHSE Specialist Commissioned Services only
Formulary Status :
Indication :
Status :
Red
Formulations :
- Capsules
Restrictions / Comments:
Important
NHSE Specialist Commissioned Services only
Formulary Status :
Indication :
Status :
Red
Formulations :
- Not Specified
Restrictions / Comments:
Important
Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
SPC
NHSE
Indication :
Status :
Non Formulary
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Not Specified
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials.
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Inhalation
Restrictions / Comments:
Important
Palliative care teams. In-patient use only.
Nitrous oxide 50% and oxygen 50%
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
For use where a PPI is not suitable and an H2RA is indicated.
For doses of 300mg, please prescribe 2x150mg as this is considerably more cost effective.
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England - specialist centres only
Formulary Status :
Links :
SPC
NHSE
Indication :
Status :
Red
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England - specialist centres only
Formulary Status :
Links :
SPC
NHSE
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
SPC
NFD1
Indication :
Status :
Green
Formulations :
- Powder
Restrictions / Comments:
Preferred
Links :
Indication :
Status :
Red
Formulations :
- Liquid
Restrictions / Comments:
Important
Only in exceptional clinical circumstances as communicated by the specialist, with an expectation to transition to powder) NOT parental convenience. Prescribe as 200ml and review need at each prescription with consideration for transition to powder
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Powder
Restrictions / Comments:
Important
Prescribe 800g tin
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Powder
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Pessaries
- Vaginal cream
Restrictions / Comments:
Formulary Status :
Links :
SPC
NFD1
Indication :
Status :
Green
Formulations :
- Oral suspension
Restrictions / Comments:
Formulary Status :
Links :